CVS HEALTH Corp (CVS)
NYSE · Retail · Retail-Drug Stores and Proprietary Stores
- Price
- $87.10
- Day
- -0.57%
- Market cap
- $111.4B
- P/E
- 22.8
Close 2026-09-22.
The company
Overview CVS Health Corporation, together with its subsidiaries (collectively, “CVS Health,” the “Company,” “we,” “our” or “us”), is a leading health solutions company building a world of health around every consumer it serves and connecting care so that it works for people wherever they are. As of December 31, 2025, we had approximately 9,000 retail locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy benefits manager with approximately 87 million plan members and expanding specialty pharmacy solutions. We serve an estimated more than 37 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (“PDP”). We are creating new sources of value through our integrated model allowing us to expand into personalized, technology driven care delivery and health services, increasing access to quality care, delivering better health outcomes and lowering overall health care costs. The Company has four reportable segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other.
From Item 1: Overview.
Institutional holders
Largest positions reported on Form 13F for the quarter ended 2026-06-30, by value.
- VANGUARD CAPITAL MANAGEMENT LLC — $8.62B
- Capital World Investors — $7.75B
- STATE STREET CORP — $6.24B
- Dodge & Cox — $5.17B
- BlackRock, Inc. — $4.06B
- WELLINGTON MANAGEMENT GROUP LLP — $3.27B
- BlackRock, Inc. — $2.85B
- VANGUARD PORTFOLIO MANAGEMENT LLC — $2.76B
Insider trades
Open-market buys and sales filed on Form 4, newest first. Grants, option exercises and tax withholding are left out.
- ROBBINS LARRY (Director) sold 370,462 shares at $93.45 on 2026-05-21
- ROBBINS LARRY (Director) sold 378,000 shares at $93.31 on 2026-05-21
- ROBBINS LARRY (Director) sold 66,881 shares at $95.67 on 2026-05-20
- ROBBINS LARRY (Director) sold 800 shares at $96.28 on 2026-05-20
- ROBBINS LARRY (Director) sold 797,628 shares at $93.48 on 2026-05-20
- ROBBINS LARRY (Director) sold 152,691 shares at $94.81 on 2026-05-20
Recent filings
- 8-K — 2026-08-17
- SCHEDULE 13G/A — 2026-08-13
- 10-Q — 2026-08-05
- 8-K — 2026-08-05
- 4 — 2026-06-29
- 4 — 2026-06-01
- 4 — 2026-06-01
- 4 — 2026-05-22
- 144 — 2026-05-22
- S-8 — 2026-05-22